COVID‐19 and ischemic stroke
COVID-19 и ишемический инсульт
2021-07-05
SCID: 54.1/uwuhrhrv
Discuss with AI
COVID-19SARS-CoV-2immune-mediated thrombosisischemic strokerenin-angiotensin system
Figures from the paper
Abstract (AI)
Since the onset of the COVID-19 pandemic, a substantial proportion of COVID-19 patients had documented thrombotic complications and ischemic stroke. Several mechanisms related to immune-mediated thrombosis, the renin angiotensin system and the effect of SARS-CoV-2 in cardiac and brain tissue may contribute to the pathogenesis of ischemic stroke in patients with COVID-19. Simultaneously, significant strains on global healthcare delivery, including ischemic stroke management, have made treatment of stroke in the setting of COVID-19 particularly challenging. In this review, we summarize the current knowledge on epidemiology, clinical manifestation, and pathophysiology of ischemic stroke in patients with COVID-19 to bridge the gap from bench to bedside and clinical practice during the most challenging global health crisis of the last decades.
Key Findings
1
COVID-19 is associated with documented thrombotic complications, including ischemic stroke, in a substantial proportion of affected patients.
2
Immune-mediated thrombosis, renin–angiotensin system dysregulation, and SARS-CoV-2 effects on cardiac and brain tissue may contribute to ischemic stroke pathogenesis.
3
The COVID-19 pandemic placed major strain on healthcare systems, making ischemic stroke treatment particularly challenging.
4
The review synthesizes current evidence on the epidemiology, clinical manifestations, and pathophysiology of ischemic stroke associated with COVID-19.
Research Object
ischemic stroke in patients with COVID-19
Research Subject
the epidemiology, clinical manifestations, pathophysiology, and treatment challenges of ischemic stroke associated with COVID-19
Publication Details
Publication Date
2021-07-05
Journal
Publisher
ISSN
Cited by
106
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Neuroinvasion of SARS-CoV-2 in human and mouse brain2020
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza2020
SARS-CoV-2 and Stroke in a New York Healthcare System2020
Stroke in COVID-19: A systematic review and meta-analysis2020
Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description2020